Article ; Online: Steroids in COVID-19: Tailor-made or "one size fits all"?
Advances in respiratory medicine
2022
Abstract: Since the RECOVERY trial, steroids have endorsed by all guidelines for treating moderate-severe COVID-19. The prescribed dose is 6mg dexamethasone or its equivalents for 10 days. However, in clinical practice, there are numerous occasions where the role ... ...
Abstract | Since the RECOVERY trial, steroids have endorsed by all guidelines for treating moderate-severe COVID-19. The prescribed dose is 6mg dexamethasone or its equivalents for 10 days. However, in clinical practice, there are numerous occasions where the role of steroids cannot be extrapolated from current evidence: patients on immunosuppression, patients with persistent oxygen requirement after ten days of therapy, etc. We highlight the existing caveats and the need for further research and discussion. |
---|---|
Language | English |
Publishing date | 2022-01-27 |
Publishing country | Switzerland |
Document type | Journal Article |
ZDB-ID | 2893877-X |
ISSN | 2543-6031 ; 2451-4934 |
ISSN (online) | 2543-6031 |
ISSN | 2451-4934 |
DOI | 10.5603/ARM.a2022.0005 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.